Wall Street Numbers logo
Wall Street Numbers logo
Wall Street Numbers
Takeda Pharmaceutical Company Limited company logo
Takeda Pharmaceutical Company Limited logo

Takeda Pharmaceutical Company Limited (TAK)

Summary

As of today, TAK price is $16.15, unchanged in the most recent trading session on
TAK price is currently -48.39% below its historical high of $31.29 set on
TAK current market cap is $51B, up +11.97% over the past 365 days
TAK current PE ratio is 39.82
TAK current annual revenue is $29.90B, down -0.51% year-over-year
The next earnings release for TAK is on

Profile

Company profile for Takeda Pharmaceutical Company Limited (TAK)
MetricValue
Full NameTakeda Pharmaceutical Company Limited
TickerNYSE: TAK
ExchangeNYSE
SectorHealthcare
IndustrySpecialty & Generic Drug Manufacturers
CountryJapan
IPO
IndexesNot included
Websitetakeda.com
Employees47,455

Key Metrics

Takeda Pharmaceutical Company Limited Key Details
MetricDateValue
Price$16.15
Price, 1D Change0.00%
Market Cap$51B
TTM Dividend Yield1.99%
PE Ratio39.82
Beta0.40
Revenue$30B
Revenue, 1Y Change-0.51%
EPS$0.40
EPS, 1Y Change+80.05%

Chart

SUGGESTED SERIES
Takeda Pharmaceutical Company Limited chart

Events

Takeda Pharmaceutical Company Limited Events
MetricDateValue
Next Earnings
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-Dividend$0.32
Next Ex-DividendN/AN/A
Last SplitN/AN/A
Next SplitN/AN/A
Last Ticker ChangeTKPYY
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

TAK Estimates
MetricDateValue
EPS$0.40
EPS EstimateN/A$94.98
EPS Est. ChangeN/A+23,824.94%
Revenue$29.90B
Revenue EstimateN/A$4,614.58B
Revenue Est. ChangeN/A+15,333.29%
Current Price$16.15
Price Target--
Price Tgt. Change--

🔒 Log In To Unlock Full Data

EPS

TAK EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
-$0.22-
$49.21$0.40-99.19%
$94.98N/A+23,824.94%
-N/A-
TAK EPS reported versus estimate values chart

Revenue

TAK revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
$4,611.64B$30.05B-99.35%
$4,531.37B$29.90B-99.34%
$4,614.58BN/A+15,333.29%
$4,681.94BN/A+15,558.57%
TAK revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

TAK Performance
MetricDateValue
Price, 1Y+10.69%
Price, 3Y+0.31%
Market Cap, 1Y+11.97%
Market Cap, 3Y+1.94%
Revenue, 1Y-0.51%
Revenue, 3Y+0.61%
EPS, 1Y+80.05%
EPS, 3Y-46.72%

🔒 Log In To Unlock Full Data

Technicals

TAK Technical Indicators
MetricDateValue
Current Price$16.15
SMA 200$15.97
SMA 200 vs Price-1.11%
SMA 50$17.25
SMA 50 vs Price+6.80%
Beta0.40
ATR$0.29
14-Day RSI37.29
10-Day Volatility18.00%
1-Year Volatility19.76%

Dividends

TAK Dividends
MetricDateValue
Last Paid$0.32
UpcomingN/AN/A
Dividend Yield4.09%
Total Dividend$0.66
$2.07B
162.43%

🔒 Log In To Unlock Full Data

Income & Profitability

TAK Income & Profitability
MetricDateValue
Revenue$29.90B
EPS$0.40
Gross Profit$15.27B
Gross Margin51.06%
Operating Profit$3.59B
Operating Margin11.99%
Net Income$1.27B
Net Margin4.26%
EBITDA$8.37B

🔒 Log In To Unlock Full Data

Financial Health

TAK Financial Health
MetricDateValue
Debt To Equity0.63
1.27
0.70
-
7
1.21

Valuations

TAK Valuations
MetricDateValue
PE Ratio39.82
1.71
1.04
9.12
N/A-

Balance Sheet

TAK Balance Sheet
MetricDateValue
Book Value$48.86B
$3.74B
$97.13B
$19.43B
$48.26B
$15.27B
Total Debt$30.69B
$3.22B
$3.09B

Expenses

TAK Expenses
MetricDateValue
$28.63B
$11.68B
$14.63B
$0.00
$4.79B
$0.00
$452.33M

Cash Flow

TAK Cash Flow
MetricDateValue
$6.23B
-$2.57B
-$2.49B
Capex$2.73B
$3.50B

Recent analyst updates

TAK Recent analyst updates
MetricDateValue
TD Cowen→
TD Cowen
B of A Securities→
Cowen & Co.→
Morgan Stanley→
JP Morgan
Cowen & Co.
Jefferies

Analyst sentiment

Sentiment over the past month
TAK analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
TAK institutional ownership distribution chart

Screeners with TAK

FAQ

  • What is the ticker symbol for Takeda Pharmaceutical Company Limited?

    The ticker symbol for Takeda Pharmaceutical Company Limited is NYSE:TAK

  • Does Takeda Pharmaceutical Company Limited pay dividends?

    Yes, Takeda Pharmaceutical Company Limited pays dividends. The last payment was $0.32, with an ex-dividend date on September 29, 2025

  • What sector is Takeda Pharmaceutical Company Limited in?

    Takeda Pharmaceutical Company Limited is in the Healthcare sector

  • What industry is Takeda Pharmaceutical Company Limited in?

    Takeda Pharmaceutical Company Limited is in the Specialty & Generic Drug Manufacturers industry

  • What country is Takeda Pharmaceutical Company Limited based in?

    Takeda Pharmaceutical Company Limited is headquartered in Japan

  • When did Takeda Pharmaceutical Company Limited go public?

    Takeda Pharmaceutical Company Limited initial public offering (IPO) was on January 5, 2010

  • Is Takeda Pharmaceutical Company Limited in the S&P 500?

    No, Takeda Pharmaceutical Company Limited is not included in the S&P 500 index

  • Is Takeda Pharmaceutical Company Limited in the NASDAQ 100?

    No, Takeda Pharmaceutical Company Limited is not included in the NASDAQ 100 index

  • Is Takeda Pharmaceutical Company Limited in the Dow Jones?

    No, Takeda Pharmaceutical Company Limited is not included in the Dow Jones index

  • When was Takeda Pharmaceutical Company Limited last earnings report?

    Takeda Pharmaceutical Company Limited's most recent earnings report was on May 13, 2026

  • When does Takeda Pharmaceutical Company Limited report earnings?

    The next expected earnings date for Takeda Pharmaceutical Company Limited is July 30, 2026

Data Sources & References

  1. TAK Official Website www.takeda.com
  2. TAK Profile on Yahoo Finance finance.yahoo.com/quote/TAK
  3. TAK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tak